Get started
Author

Richard I. Malamut

Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations
2012 · Robert H. Dworkin, Dennis C. Turk, et al. · Pain · 285
The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale
2011 · Horacio Kaufmann, Richard Malamut, et al. · Clinical Autonomic Research · 246
Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendations
2016 · Ann M. Taylor, Kristine Phillips, et al. · Pain · 208
Usefulness of electrodiagnostic techniques in the evaluation of suspected tarsal tunnel syndrome: An evidence‐based review
2005 · Atul T. Patel, Kenneth Gaines, et al. · Muscle & Nerve · 158
Research design considerations for chronic pain prevention clinical trials
2015 · Jennifer S. Gewandter, Robert H. Dworkin, et al. · Pain · 142
Nerve conduction studies in Charcot‐Marie‐Tooth polyneuropathy associated with a segmental duplication of chromosome 17
1993 · D. A. Kaku, G. J. Parry, et al. · Neurology · 118
Uniform slowing of conduction velocities in Charcot‐Marie‐Tooth polyneuropathy type 1
1993 · D. A. Kaku, G. J. Parry, et al. · Neurology · 110
Postsurgical idiopathic brachial neuritis
1994 · Richard I. Malamut, Wilson Marques, et al. · Muscle & Nerve · 96
Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations
2015 · Maciej Gasior, Mary Bond, et al. · Postgraduate Medicine · 90
PDF
Safety and Efficacy of a Topical Sodium Channel Inhibitor (TV-45070) in Patients With Postherpetic Neuralgia (PHN)
2016 · Nicola Price, Rostam Namdari, et al. · Clinical Journal of Pain · 68
Improving Study Conduct and Data Quality in Clinical Trials of Chronic Pain Treatments: IMMPACT Recommendations
2019 · Jennifer S. Gewandter, Robert H. Dworkin, et al. · Journal of Pain · 56
Abuse-Deterrent Formulations of Prescription Opioid Analgesics in the Management of Chronic Noncancer Pain
2016 · Martin E Hale, Derek Moe, et al. · Pain Management · 46
PDF
Conduction block as an early sign of reversible injury in ischemic monomelic neuropathy
1993 · David A. Kaku, Richard I. Malamut, et al. · Neurology · 44
Patient engagement in designing, conducting, and disseminating clinical pain research: IMMPACT recommended considerations
2023 · Simon Haroutounian, Katherine J. Holzer, et al. · Pain · 39
Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations
2021 · Jennifer S. Gewandter, Robert H. Dworkin, et al. · PAIN Reports · 33
Isolation of a marker linked to the Charcot-Marie-Tooth disease type IA gene by differential Alu-PCR of human chromosome 17-retaining hybrids.
1990 · P I Patel, C Garcia, et al. · PubMed · 32
Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations
2012 · Dennis C. Turk, Alec B. O’Connor, et al. · Pain · 31
PDF
Understanding chronic inflammatory and neuropathic pain
2012 · Jane P. Hughes, Iain Chessell, et al. · Annals of the New York Academy of Sciences · 31
Research objectives and general considerations for pragmatic clinical trials of pain treatments: IMMPACT statement
2023 · David J. Hohenschurz-Schmidt, Dan Cherkin, et al. · Pain · 27
Efficacy and safety of a hydrocodone extended-release tablet formulated with abuse-deterrence technology in patients with moderate-to-severe chronic low back pain
2015 · Martin E. Hale, MD, Thomas R. Zimmerman, MD, et al. · Journal of Opioid Management · 19
Methods for pragmatic randomized clinical trials of pain therapies: IMMPACT statement
2024 · David Hohenschurz-Schmidt, Dan Cherkin, et al. · Pain · 18
Efficacy and tolerability of a hydrocodone extended-release tablet formulated with abuse-deterrence technology for the treatment of moderate-to-severe chronic pain in patients with osteoarthritis or low back pain
2015 · Martin Hale, Charles Laudadio, et al. · Journal of Pain Research · 15
PDF
Participant Preferences for Pharmacologic Chronic Pain Treatment Trial Characteristics: An ACTTION Adaptive Choice-Based Conjoint Study
2016 · Shannon M. Smith, Jennifer S. Gewandter, et al. · Journal of Pain · 14
Diabetic retinopathy: treating systemic conditions aggressively can save sight.
2005 · S. H Sinclair, R. Malamut, et al. · Cleveland Clinic Journal of Medicine · 10
Six-month, open-label study of hydrocodone extended release formulated with abuse-deterrence technology: Safety, maintenance of analgesia, and abuse potential
2016 · Martin E. Hale, MD, Yuju Ma, MS, et al. · Journal of Opioid Management · 8
Works count: 44
Citation count: 1,979
H-index: 19
I10-index: 24
Year
Topic
Type